The Brave New World of Head and Neck Pathology: Updates on the WHO and More Course

The Brave New World of Head and Neck Pathology: Updates on the WHO and More Course is organized by United States and Canadian Academy of Pathology (USCAP).

Original release date: July 3, 2018
Access to this course expires on: June 2, 2021

Accreditation:
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 12 SAM/Part II credit hours.

Course Description:
Head and neck pathology represents a significant portion of surgical pathology practice. Studies have shown this area to be particularly treacherous for community pathologists, with up to 53% of diagnoses changed (including 7% with major changes) upon second review at tertiary care hospitals.

Complicating this inherent difficulty, there have been numerous recent developments in the field of head and neck pathology. Novel entities have been described, pathognomonic molecular alterations have been uncovered, and major shifts in diagnostic classification schemes have been proposed. Many of these concepts were incorporated into the newest editions of the WHO Classifications for Head and Neck and Endocrine Tumors, both of which were published this year.

Learning Objectives:
Upon completion of this educational activity, learners will be able to:
• Develop a diagnostic approach to the encapsulated follicular-patterned thyroid nodule 
• Develop a diagnostic approach to the "small round blue cell" sinonasal tumor 
• Describe the algorithmic approach to HPV testing in a head and neck cancer 
• Recognize the updated WHO terminology of salivary gland carcinomas 
• Recognize the appropriate WHO grading scheme for squamous dysplasia in the larynx